A liquid biopsy can be used for molecular characterization of the tumor and its non-invasive nature allows repeat sampling to monitor genetic changes over time without the need for a tissue biopsy. According to market research study published by Gen Consulting Company, the global non-invasive liquid biopsy market stood at around USD 1,467 million in 2020 and is projected to rise to a worth of USD 4,072 million by 2027 end, thereby garnering a CAGR of 15.7% during 2021-2027.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global non-invasive liquid biopsy market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The non-invasive liquid biopsy market is segmented on the basis of product, technology, sample, application, and application. The non-invasive liquid biopsy market is segmented as below:

By product:

  • kits and assays
  • services



By technology:

  • polymerase chain reaction (PCR)
  • sequencing
  • microarray
  • others



By sample:

  • faeces
  • urine
  • saliva
  • others



By application:

  • application
  • oncology
  • reproductive health
  • metabolic disorders
  • others



By region:

  • Asia Pacific
  • Europe
  • North America
  • Rest of the World (RoW)



The report explores the recent developments and profiles of key vendors in the Global Non-Invasive Liquid Biopsy Market, including Analytik Jena AG, EXACT Sciences Corporation, Exosome Diagnostics, Inc. (Bio-Techne Corporation), Lonza Group AG (Exosomics Siena S.p.A), MDxHealth BV, Merck KGaA, OraSure Technologies, Inc., PerkinElmer, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

  • To analyze and forecast the market size of the global non-invasive liquid biopsy market.
  • To classify and forecast the global non-invasive liquid biopsy market based on product, technology, sample, application, and application.
  • To identify drivers and challenges for the global non-invasive liquid biopsy market.
  • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global non-invasive liquid biopsy market.
  • To identify and analyze the profile of leading players operating in the global non-invasive liquid biopsy market.



Why Choose This Report

  • Gain a reliable outlook of the global non-invasive liquid biopsy market forecasts from 2021 to 2027 across scenarios.
  • Identify growth segments for investment.
  • Stay ahead of competitors through company profiles and market data.
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.